• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

16
16
15
14
14

COUNTRY

12
2
2

CATEGORIES

  • 15
  • 13
  • 10
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
2
20
35

PUBLISHED

0
0
1
35

PRODUCT TYPE

34
1

Search "Snapshots Hungary Pharmaceuticals 2008" returned 35 results.

Pharmaceuticals - Global Outlook

The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings Punctuated with 46 statistically rich tables, the...

January 2012
FROM

Hungary Pharmaceuticals and Healthcare Report Q2 2013

BMI View The Hungarian government's harsh measures aimed at reducing its debt have severely affected the domestic market for pharmaceutical companies, which have posted steep declines in domestic...

March 2013

Central and Eastern Europe OTC Drugs Industry Outlook to 2017 - Expanding Access to Distribution Channels to Lead Sales Growth

The report titled “Central and Eastern Europe OTC Drugs Industry Outlook to 2017- Expanding Access to Distribution Channels to Lead Sales Growth ” presents a comprehensive analysis of the industry covering...

January 2014
FROM

Analyzing the Global Generics Industry 2014

In recent times there has been a growing focus on the generic drugs industry worldwide The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the...

August 2014
FROM
Sun Pharmaceutical Industries Limited - Product Pipeline Review - H2 2011 Sun Pharmaceutical Industries Limited - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Sun Pharmaceutical Industries Limited - Product Pipeline Review - H2 2011

Sun Pharmaceutical Industries Limited – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Sun Pharmaceutical Industries Limited - Product Pipeline Review -...

November 2011
FROM

Hungary Pharmaceuticals and Healthcare Report Q4 2012

The Hungary Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

September 2012

Hungary Pharmaceuticals and Healthcare Report Q1 2013

BMI View: Our outlook for Hungary's pharmaceutical market remains negative, given the government's policies that shift the burden of the National Healthcare Fund (OEP) on to drug manufacturers. Pricing...

January 2013

Hungary Pharmaceuticals and Healthcare Report Q3 2012

The Hungary Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

May 2012

Hungary Pharmaceuticals and Healthcare Report Q4 2011

Business Monitor International's Hungary Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

August 2011

Hungary Pharmaceuticals and Healthcare Report Q2 2012

Business Monitor International's Hungary Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

February 2012

Hungary Pharmaceuticals and Healthcare Report Q1 2012

Business Monitor International's Hungary Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

November 2011

Hungary Pharmaceuticals and Healthcare Report Q1 2010

Business Monitor International's Hungary Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

November 2009

Turkey Pharmaceuticals and Healthcare Report Q4 2009

This Turkey Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

August 2009
Biorepositories: Ownership & End-Users - A Global Market Watch, 2009-2015 Biorepositories: Ownership & End-Users - A Global Market Watch, 2009-2015 - Product Thumbnail Image

Biorepositories: Ownership & End-Users - A Global Market Watch, 2009-2015

REPORT DESCRIPTION Global Market Watch: With a CAGR of 7 9%, global market value for biorepositories market is anticipated to be worth US$23 9 billion by 2015 On a global scale, North America accounts...

November 2011
FROM
Biorepositories: Technologies & End-Users - A Global Market Watch, 2009-2015 Biorepositories: Technologies & End-Users - A Global Market Watch, 2009-2015 - Product Thumbnail Image

Biorepositories: Technologies & End-Users - A Global Market Watch, 2009-2015

REPORT DESCRIPTION Global Market Watch: With a CAGR of 7 9%, global market value for biorepositories market is anticipated to be worth US$23 9 billion by 2015 On a global scale, North America accounts...

November 2011
FROM
Biorepositories: Applications & End-Users - A Global Market Watch, 2009-2015 Biorepositories: Applications & End-Users - A Global Market Watch, 2009-2015 - Product Thumbnail Image

Biorepositories: Applications & End-Users - A Global Market Watch, 2009-2015

REPORT DESCRIPTION Global Market Watch: With a CAGR of 7 9%, global market value for biorepositories market is anticipated to be worth US$23 9 billion by 2015 On a global scale, North America accounts...

November 2011
FROM

Turkey Pharmaceuticals and Healthcare Report Q4 2010

The Turkey Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent...

August 2010

Czech Republic Pharmaceuticals and Healthcare Report Q2 2011

The Czech Republic Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies...

April 2011
Private Equity in Hungary 2011: Growth and Investment Opportunities Private Equity in Hungary 2011: Growth and Investment Opportunities - Product Thumbnail Image

Private Equity in Hungary 2011: Growth and Investment Opportunities

Hungary needed bailout by the IMF and had to implement austerity measures to tackle its widening budget deficit The country's credit rating has been further downgraded due to increased concern that...

May 2012

Czech Republic Pharmaceuticals and Healthcare Report Q4 2009

The Czech Republic Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies...

October 2009
Loading Indicator

Our Clients

Goodyear Tire & Rubber Company GlaxoSmithKline PLC Hilton Worldwide Hewlett-Packard Company Accenture PLC. Qualcomm Incorporated UBS AG